BETA

11 Amendments of Gesine MEISSNER related to 2017/2254(INI)

Amendment 26 #
Motion for a resolution
Recital A a (new)
Aa. whereas at least 20% of healthcare-associated infections (HAIs) are estimated to be preventable by sustained and multifaceted infection prevention and control programmes1a; _________________ 1a https://ecdc.europa.eu/sites/portal/files/me dia/en/publications/Publications/healthca re-associated-infections-antimicrobial- use-PPS.pdf
2018/03/07
Committee: ENVI
Amendment 45 #
Motion for a resolution
Recital C
C. whereas healthcare-associated infections (HAI) are often dueoccur due to lacking prevention measures which lead to antibiotic-resistant bacteria; whereas the European Centre for Disease Prevention and Control (ECDC) estimates that approximately 4 million patients acquire a HAI each year in the EU and that approximately 37 000 deaths result directly from these infections;
2018/03/07
Committee: ENVI
Amendment 117 #
Motion for a resolution
Paragraph 2 a (new)
2a. Calls on the Commission and Member States to distinguish between livestock and pets particularly in the design of monitoring and assessment of the use of antimicrobials in veterinary medicine, as well as in the design of measures to address their use;
2018/03/07
Committee: ENVI
Amendment 172 #
6a. Stresses that compliance to infection control guidelines, integrating targets for infection rate reductions and supporting best practice all help address patient safety in the hospital environment;
2018/03/07
Committee: ENVI
Amendment 228 #
Motion for a resolution
Paragraph 11
11. Calls Stresses that particularly in rural areas it is challenging to respond the Commission and the Member States to restrict or stopo livestock health issues in good time and that therefore in some regions it has proven irreplaceable to allow veterinarians to directly supply antibiotics; calls on the Commission and the Member States to only address the sale of antibiotics by those doctors or veterinarians who prescribe them in a way that still allows a sufficiently fast supply of antibiotics for veterinary use in livestock;
2018/03/07
Committee: ENVI
Amendment 275 #
Motion for a resolution
Paragraph 13 a (new)
13 a. Stresses that the release of pharmaceutical residues including antimicrobials through wastewater from hospitals and households is considered to be a major source of pharmaceutical residues in waters and the environment; welcomes in this regard the Commission's Strategic Roadmap to Pharmaceuticals in the Environment1a and EU-funded projects such as the PILLS project1b on wastewater treatment; stresses the importance of proper waste water treatment for the fight against AMR and therefore urges the Commission and Member States to consider further measures to increase the application of the so-called fourth purification stage in communal waste water treatment as well as at the major points of release, such as hospitals; _________________ 1a Ares(2017)2210630 1b http://www.pills-project.eu/
2018/03/07
Committee: ENVI
Amendment 287 #
Motion for a resolution
Paragraph 14
14. Calls for environmental risk assessments as part of the marketing authorisation process for antimicrobials;deleted
2018/03/07
Committee: ENVI
Amendment 320 #
Motion for a resolution
Paragraph 15 a (new)
15 a. Urges the European Commission to consider a new legislative framework to stimulate the development of new antimicrobials for humans, as already requested by the European Parliament on 10 March 2016 on the proposal for a regulation of the European Parliament and of the Council on veterinary medicinal products and in the parliamentary resolution (2015) 0197 of19 May 2015; notes that the Commission “One Health” Action Plan against AMR also commits itself to “analyse EU regulatory tools and incentives - in particular orphan and paediatric legislation – to use them for novel antimicrobials".
2018/03/07
Committee: ENVI
Amendment 347 #
Motion for a resolution
Paragraph 18 a (new)
18 a. Welcomes recent cross-border research projects into antimicrobial stewardship and the prevention of infection, such as the EU-funded i-4-1- Health Interreg project; calls on the Commission to increase research funding for measures to prevent healthcare- associated infections (HAI);
2018/03/07
Committee: ENVI
Amendment 359 #
Motion for a resolution
Paragraph 21
21. Calls on the Commission and the Member States to support the implementation of new economic models, pilot projects and incentives to boost the development of new diagnostics, antibiotics, alternamedicines and medical devices; believing that that these are meaningful when they are sustainable over the long term, target key public prioritives, and vaccinessupport appropriate medicinal use;
2018/03/07
Committee: ENVI
Amendment 371 #
Motion for a resolution
Paragraph 21 a (new)
21 a. Encouraging the uptake of cost- effectiveness technologies that reduce the impact of health associated infections (HAIs) in hospitals and help preventing the spread of multi-resistant microorganisms
2018/03/07
Committee: ENVI